BTWM
Baker Tilly Wealth Management’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,693
| Closed | -$459K | – | 307 |
|
|
2024
Q1 | $459K | Sell |
1,693
-11
| -0.6% | -$2.98K | 0.08% | 275 |
|
|
2023
Q4 | $403K | Sell |
1,704
-57
| -3% | -$13.5K | 0.07% | 335 |
|
|
2023
Q3 | $345K | Sell |
1,761
-112
| -6% | -$22K | 0.06% | 340 |
|
|
2023
Q2 | $394K | Buy |
1,873
+154
| +9% | +$32.4K | 0.04% | 398 |
|
|
2023
Q1 | $347K | Buy |
1,719
+139
| +9% | +$28.1K | 0.04% | 420 |
|
|
2022
Q4 | $344K | Sell |
1,580
-97
| -6% | -$21.1K | 0.04% | 408 |
|
|
2022
Q3 | $330K | Sell |
1,677
-48
| -3% | -$9.45K | 0.05% | 395 |
|
|
2022
Q2 | $369K | Sell |
1,725
-30
| -2% | -$6.42K | 0.05% | 375 |
|
|
2022
Q1 | $498K | Buy |
1,755
+1
| +0.1% | +$284 | 0.06% | 346 |
|
|
2021
Q4 | $661K | Buy |
1,754
+82
| +5% | +$30.9K | 0.07% | 299 |
|
|
2021
Q3 | $690K | Buy |
1,672
+91
| +6% | +$37.6K | 0.09% | 248 |
|
|
2021
Q2 | $585K | Buy |
1,581
+325
| +26% | +$120K | 0.09% | 241 |
|
|
2021
Q1 | $364K | Buy |
1,256
+228
| +22% | +$66.1K | 0.07% | 309 |
|
|
2020
Q4 | $257K | Buy |
+1,028
| New | +$257K | 0.08% | 272 |
|